Cynosure (CYNO) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St falls as oil ticks up, yields rise ahead of US-China summit
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
Cynosure Announces Third-Quarter 2015 Results; Revenue of $78.4 Million, 10 Percent Increase from Prior Year
October 27, 2015 8:00 AM EDTWESTFORD, Mass., Oct. 27, 2015 /PRNewswire/ --
Third-Quarter Highlights:
North America product revenue growth of 29 percent Non-GAAP earnings of $0.21 per share; GAAP earnings of $0.14 per share Cash and investments of $153.3 million at September 30, 2015 Initiated U.S. pre-launch of SculpSure for non-invasive fat reductionCynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for... More
